P-50 Hereditary angioedema breakthrough: FXII mutation discovery and the power of Icatibant and Lanadelumab Aviv Talmon, Limor Rubin, Yaarit Ribak, Oded Shamriz, Mariana Druker, Inon Sarig, Eyal Ben Dori, Yuval Tal Allergy and Clinical Immunology Unit, Department of Medicine, Hadassah Medical Organization, Faculty of Medicine, Hebrew University of Jerusalem, Israel Allergy, Asthma & Clinical Immunology 2025, 21(Suppl 2) :P-50 Background, Objectives: Hereditary angio-edema (HAE) is a rare, life-threatening disorder characterized by recurrent angioedema episodes
A randomized controlled trial using glycemic plus fetal ultrasound parameters versus glycemic parameters to determine insulin therapy in gestational diabetes with fasting hyperglycemia
Additionally, commenters noted that these expenses are not negated by the software available for free from the measure steward, as the measure requires working with a third-party vendor
Proteomic Analysis of S-Acylated Proteins in Human B Cells Reveals Palmitoylation of the Immune Regulators CD20 and CD23
